Oxidative stress-related mechanisms are associated with xenobiotics exerting excess toxicity to Fanconi anemia cells. by Pagano, Giovanni et al.
A number of organic and inorganic xenobiotics
exert their toxicity via a sequence of mecha-
nisms that relate to redox-related biotransfor-
mation (Bagchi et al. 2002; Balamurugan et al.
2002; Dusre et al. 1990; Ercal et al. 2001;
Penketh et al. 2001; Quievryn et al. 2001;
Sawamura et al. 1996; Seaton et al. 1995).
These mechanisms include a number of dis-
tinct events that may result in direct oxidative
damage, such as the formation of reactive oxy-
gen species (ROS), the occurrence of redox
couples {e.g., chromium [Cr(VI)/Cr(III)]}, and
the formation of reactive intermediates of the
native molecule (Dusre et al. 1990; Ercal et al.
2001; Gutteridge et al. 1984; Pagano 2002;
Stohs and Bagchi 1995). As a possible alterna-
tive, the action mechanisms of some xenobi-
otics may interfere with some essential
antioxidant systems, for example, the glu-
tathione (GSH) system, thus resulting in 
a redox imbalance (Spanò et al. 1998;
Vlachodimitropoulos et al. 1997).
In many instances, a combination of
effects may occur, for example, related to
a) ROS activity, b) modulation of redox-
related activities and/or of thiol antioxidants,
and/or c) the speciﬁc action of xenobiotic end
product(s) (e.g., cross-linking with biopoly-
mers) (Pagano 2002). The mechanistic fea-
tures for any class of agents imply the extent to
which these events may prevail, also depending
on the individual structure analogs being con-
sidered, as well as other factors related to extra-
and intracellular environment, for example,
ambient oxygen levels, the endogenous redox-
related activities, pH and other ionic balance,
and the co-presence of other bioactive agents
(hormones or other xenobiotics).
A set of xenobiotics has been reported to
exert enhanced toxicity to cells from patients
with Fanconi anemia (FA), a cancer-prone
genetic disease (Ahmad et al. 2002; Alter
1996; Auerbach et al. 1998). The excess sensi-
tivity of FA cells is used in FA diagnosis and is
commonly attributed to the inability of FA
cells to repair DNA cross-links induced by
these agents. This subject has direct implica-
tions in disease deﬁnition, because the axiom
of “cross-linker sensitivity” is related to the
widespread opinion that FA is a DNA repair
deﬁciency syndrome. In this commentary we
review the published evidence for the involve-
ment of several (and distinct) redox-related
mechanisms in the toxicities of all the xenobi-
otics that have been reported to trigger
enhanced sensitivity in FA cells, and we discuss
the role for cross-link formation and removal.
Xenobiotics Involved in
Deﬁning FA Phenotype
Mitomycin C. Since the report by Iyer and
Szybalski (1964), the requirement for redox
biotransformation of mitomycin C (MMC)
has been well recognized in pharmacology,
because MMC must be activated by a series of
redox reactions leading to semiquinone deriva-
tives coupled with ROS formation (Dusre et
al. 1990; Gutteridge et al. 1984; Penketh et al.
2001; Pritsos and Sartorelli 1986). Well-estab-
lished mechanistic information has shown that
MMC-associated toxicity is dependent on oxy-
gen levels (Clarke et al. 1997; Korkina et al.
2000) and is removed by low-molecular-
weight antioxidants (Raj and Heddle 1980)
and by thioredoxin (Trx) overexpression
(Ruppitsch et al. 1998). Recent reports
demonstrate that a) MMC exposure results in
an increase in oxidative DNA damage
(Pagano et al. 2001); b) FA cells fail to accu-
mulate higher MMC adduct levels in DNA
than control cells (Rutherford et al. 1999;
Will et al. 1998); and c) the ratio of MMC
biadducts to monoadducts (reflective of a
DNA repair defect) shows no difference in FA
cells compared with normal cells (Rutherford
et al. 1999). In a previous study, Clarke et al.
(1997) had shown that MMC-induced apop-
tosis in FA complementation group C (FA-C)
cells occurred under normoxic conditions
(associated with redox-cycling mechanisms),
whereas MMC was ineffective in causing
apoptosis under hypoxic conditions (with pre-
vailing cross-link formation).
Diepoxybutane. Diepoxybutane (DEB)
toxicity may be indirectly associated with
redox mechanisms because its epoxide struc-
ture implies susceptibility to GSH scavenging
(Bartók and Láng 1980). Similar to MMC,
DEB-associated toxicity correlates with oxy-
gen levels (Korkina et al. 2000) and oxidative
DNA damage (Pagano et al. 2001), whereas
DEB-induced cytotoxicity and DNA dam-
age are decreased by Trx overexpression
(Ruppitsch et al. 1998). DEB toxicity is mod-
ulated by GSH, and in turn, DEB results in
GSH depletion (Korkina et al. 2000; Spanò
et al. 1998; Vlachodimitropoulos et al. 1997).
Thus, a major feature of DEB-induced toxic-
ity may be related to an imbalance in GSH
levels resulting in a cellular prooxidant state.
Cisplatin. After the early report by Poll et
al. (1982) showing excess sensitivity of FA cells
to platinum compounds, cisplatin (CDDP)-
associated toxicity has been regarded as an
example of cross-linkers exerting enhanced tox-
icity to FA cells (Auerbach et al. 1998). Further
studies, however, have provided mechanistic
evidence for CDDP biotransformation leading
to oxidative stress along with a cascade of
redox-associated events. It has been recognized
that oxidative pathways participate in the char-
acteristic nephrotoxicity of CDDP, including
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Research Commentaryinduction of heme oxygenase-1 (Schaaf et al.
2002), and CDDP-induced cytotoxicity and
ROS formation are effectively counteracted by
antioxidants such as α-tocopherol, vitamin C,
and N-acetylcysteine (NAC) (De Martinis and
Bianchi 2001; Schaaf et al. 2002). Treatment of
myeloma cells with NAC completely blocked
CDDP-dependent intracellular GSH oxida-
tion, ROS generation, poly(ADP-ribose) poly-
merase cleavage, and apoptosis (Godbout et al.
2002). Bauman et al. (1991) reported a protec-
tive role of metallothionein, a scavenger of
hydroxyl radicals, against a number of oxidative
stress–associated xenobiotics, including CDDP.
Waisﬁsz et al. (2002) have demonstrated
that p21waf1/Cip1, an oxidative stress regulatory
gene (Esposito et al. 1998), is overexpressed in
lymphoblastoid FA cells and is very sensitive
to CDDP. p21waf1/Cip1 is known to be a key
regulator of G1 cell-cycle arrest and has been
recently linked to G2 cell-cycle regulation
(Taylor and Stark 2001). This observation ﬁts
well with the previously observed up-regula-
tion of apoptotic regulatory p53 protein and
cyclin B proteins, inactivation of CDC2
kinase, and cell-cycle arrest, which follows
exposure to low doses of cross-linking agents
in FA cells (Kruyt et al. 1996, 1997; Kupfer
and D’Andrea 1996). Also p53, cyclin B, and
CDC2 kinase are known to be involved in
oxidative stress pathways (Barnouin et al.
2002; Chen et al. 2002; Chuang et al. 2002).
Hence, the literature provides cellular and
molecular evidence for a direct involvement of
redox pathways in CDDP-associated toxicity
mechanisms.
8-Methoxypsoralen and ultraviolet A. Early
studies pointed to the excess sensitivity of FA
cells to 8-methoxypsoralen (8-MOP) plus
ultraviolet A (UVA) irradiation (PUVA), and
the results were construed as due to inability to
cope with 8-MOP cross-link formation
(Moustacchi and Diatloff-Zito 1985). The
combination of PUVA, however, is associated
with production of ROS that react subse-
quently with DNA, lipids, and proteins and
cause a decrease in cellular antioxidative capac-
ity (Reinheckel et al. 1999). Both UVA irradia-
tion and PUVA treatment induced signiﬁcant
changes in the distribution of arachidonic acid
and increased the liberation of arachidonic acid
from membrane phospholipids, with a signiﬁ-
cant increase in the formation of thiobarbituric
acid–reactive material. The activities of the
antioxidant enzymes catalase and superoxide
dismutase were also signiﬁcantly decreased by
UVA (Punnonen et al. 1991). PUVA-associ-
ated toxicity has been shown to cause GSH
depletion (d’Ischia et al. 1989), which in turn
involves an oxidative stress condition.
Chromium(VI). In a recent article,
Vilcheck et al. (2002) reported on excess sensi-
tivity of FA complementation A group (FA-A)
cells to Cr(VI)-induced toxicity and apoptosis.
Cell growth and apoptosis were measured by
phosphatidylserine translocation and caspase-3
activation. Both the induction of apoptosis and
of clonogenicity showed signiﬁcantly increased
sensitivity to Cr(VI) in FA-A cells versus con-
trol ﬁbroblasts. However, no increase in Cr(VI)
uptake or in Cr–DNA adducts was detected in
FA-A cells versus control cells.
Vilcheck et al. (2002) relied on the
assumptions that FA phenotype and Cr-asso-
ciated toxicity should be based on a) excess
sensitivity to DNA cross-linking agents, sug-
gesting “a general defect in the repair of DNA
cross-links” and b) the ultimate events in Cr-
associated toxicity, namely, the formation of
DNA lesions, such as DNA–Cr–DNA inter-
strand cross-links (Bridgewater et al. 1998;
Mattagajasingh and Misra 1999; O’Brien et
al. 2001; Singh et al. 1998). However, this
study provides support to the body of evi-
dence relating oxidative stress both to FA
phenotype and to Cr toxicity. 
An extensive body of literature has pro-
vided evidence for the role of multiple redox-
related events in Cr-associated toxicity, as
summarized in Table 1. These events include
both direct and indirect mechanisms related
to oxidative stress, for example, Cr-induced
depletion of GSH and other thiol-based
antioxidants (Nguyen-nhu and Knoops 2002;
O’Brien et al. 2001; Quievryn et al. 2001);
protective effects of catalase, melatonin, or
NAC (Cabrer et al. 2001; Izzotti et al. 1998;
Shi et al. 1999); ROS formation (Bagchi et al.
2001; Hassoun and Stohs 1995; Izzotti et al.
1998; Tsou et al. 1996); nitric oxide produc-
tion (Hassoun and Stohs 1995); and lipid
peroxidation (Bagchi et al. 1995, 1997). The
eventual formation of Cr adducts to DNA, or
to proteins and DNA, may be viewed as an
ultimate step in a set of redox-dependent
mechanisms (Blasiak and Kowalik 2000;
Hodges et al. 2001).
As shown in Tables 2 and 3, the xenobi-
otics commonly used in FA diagnosis (MMC,
DEB), or otherwise associated with excess
sensitivity in FA cells (CDDP, PUVA), dis-
play distinct mechanisms of toxicity that,
however, involve redox-dependent actions
interrelated with ROS formation and/or oxy-
gen levels, and/or modulation of antioxidant
levels, and/or antioxidant enzyme activities.
These mechanistic features, conversely, may
suggest a redox imbalance in FA cells, as far as
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Table 1. Summary of the published evidence for the association of Cr toxicity with oxidative stress.
End points Observations References
Oxidative stress and tissue damage ↑ DNA damage, apoptosis, altered gene  Bagchi et al. (1995; 2002),
expression; urinary lipid metabolites;  Hassoun and Stohs (1995),
nitric oxide production and ROS formation Travacio et al. (2000)
p53 expression ↑ Oxidative damage in p53-null mice Bagchi et al. (2001)
ROS- and Src-dependent apoptosis Induced by Cr(III) complexes involved Balamurugan et al. (2002)
in ROS generation
Lipid and DNA oxidation Counteracted by melatonin Cabrer et al. (2001)
8-OHdG in vivo formation Suppressed by NAC Tsou et al. (1996),
Izzotti et al. (1998), 
Hodges et al. (2001)
GSH- and cysteine-associated Preferential cross-linking of GSH to DNA; O’Brien et al. (2001),
protection toward DNA cross-linking in vivo role of cysteine in reduction of Cr(VI) Quievryn et al. (2001)
Table 2. Summary of the published evidence for the redox-dependent mechanisms in MMC- and DEB-
associated toxicity.
End points Observations References
MMC
FA-group C cell apoptosis Modulated by oxygen levels Clarke et al. (1997)
Biotransformation to toxic  Effected by a set of redox activities;  Iyer and Szybalski (1964), 
derivatives associated with ROS (·OH) formation Gutteridge et al. (1984), Pritsos
and Sartorelli (1986), Dusre
et al. (1990), Penketh et al. 
(2001)
Embryotoxicity Modulated by oxygen levels; Korkina et al. (2000), Pagano 
↑ 8-OHdG formation et al. (2001) 
Chromosomal instability Modulated by low-molecular-weight Nordenson (1977), Raj and 
antioxidants, thioredoxin over- Heddle (1980), Ruppitsch et al. 
expression, and redox-related  (1998)
enzymes
DEB
Cytotoxicity and embryotoxicity Modulated by GSH levels, Vlachodimitropoulos et al. (1997),
oxygen levels, and thioredoxin  Spanò et al. (1998), Ruppitsch 
overexpression; ↑ 8-OHdG  et al. (1998), Korkina et al. 
formation (2000), Pagano et al. (2001)
8-OHdG, 8-hydroxy-2´-deoxyguanosine.they display a prooxidant state making them
unable to cope with prooxidant xenobiotics.
Prooxidant State in FA
Phenotype
FA is a genetic disorder associated with bone
marrow failure, chromosomal instability, and
poor prognosis (Alter 1996; Auerbach et al.
1998). FA shows a progression to aplastic
anemia, excess risk of malignancy (mainly
nonlymphocytic leukemia), a set of typical
malformations, and altered skin pigmenta-
tion. A total of eight complementation groups
have been identiﬁed, and six genes (FANCA,
FANCC,  FANCD2,  FANCE,  FANGF,
FANCG) have been cloned so far (Tamary et
al. 2002). Diagnosis is performed by excess
FA cell sensitivity to either DEB or MMC
that induces high rates of chromosomal
breaks (Auerbach and Wolman 1976). A line
of molecular evidence has related at least two
FA gene–encoded proteins with redox path-
ways. The protein encoded by the Fanconi
gene C (FANCC) has been shown to associate
with redox-related activities, namely,
NADPH cytochrome P450 reductase (Kruyt
et al. 1998) and glutathione S-transferase
(Cumming et al. 2001). A recent study has
provided evidence that the FANCG protein
interacts with cytochrome P450 2E1 protein,
an activity also known to be involved in redox
biotransformation of xenobiotics (Futaki et al.
2002). Previous indirect evidence for an
abnormal regulation of xenobiotic biotrans-
formation in FA cells was provided by Joenje
and Oostra (1986), who reported excess sensi-
tivity of FA cells to cyclophosphamide with-
out S-9 metabolic activation (Madle 1981).
This finding suggested that FA cells, unlike
non-FA cells, were endowed with a complete
set of phase 1 activities for cyclophosphamide
biotransformation. 
The relationship of the FA phenotype with
a prooxidant state was first suggested by
Nordenson (1977). A consistent body of 
evidence has been accumulated since then,
both related to phenotypic redox abnormalities
and related to the involvement of FA proteins
in redox pathways (Ahmad et al. 2002;
Bogliolo et al. 2002; Pagano et al. 1998;
Pagano and Korkina 2000; Pagano and
Youssouﬁan 2003), as summarized in Table 4.
FA cells are characterized by a) excess oxidative
DNA damage [8-hydroxy-2´-deoxyguanosine
(8-OHdG)] in hydrogen peroxide-exposed FA
cells (Takeuchi and Morimoto 1993), and in
freshly drawn white blood cells from FA
patients (Degan et al. 1995); b) increased oxy-
gen sensitivity (Joenje et al. 1981) and sensitiv-
ity to free iron (Poot et al. 1996); c) correction
of chromosomal abnormalities by either
antioxidant enzymes or by low-molecular-
weight antioxidants (Dallapiccola et al. 1985;
Nordenson 1977; Raj and Heddle 1980);
d) excess plasma levels of clastogenic factor
(Emerit et al. 1995) and of tumor necrosis fac-
tor-α (TNF-α; Dufour et al. 2003; Schulz
and Shahidi 1993); e) involvement of redox-
active cytokines, such as TNF-α and inter-
feron-γ (Dufour et al. 2003; Pearl-Yafe et al.
2003), and of inducible nitric oxide synthase
(Hadjur and Jirik 2003); and d) an involve-
ment of Trx, which corrects MMC and DEB
sensitivity in FA cells (Ruppitsch et al. 1998)
and occurs in lower-than-normal levels in FA
ﬁbroblasts (Kontou et al. 2002). Together, a
well-established body of evidence on FA cellu-
lar phenotype, along with the roles for some
FA proteins in redox pathways (Bogliolo et al.
2002; Pagano and Youssoufian 2003), com-
bine to support a central role for oxidative
stress both in FA cellular phenotype and in FA
protein functions.
Conclusions and Suggestions
Well-established literature points to the
involvement of redox-dependent mechanisms
in the toxicity of MMC, DEB, CDDP,
PUVA, and Cr(VI). The formation of DNA
or protein–DNA cross-links may be viewed as
the outcome of redox reactions coupled with
ROS formation, antioxidant (e.g., GSH)
depletion, and a multifaceted modulation of
redox-related activities.
When these xenobiotics interact with FA
cells, which are in turn characterized by a
multiple prooxidant state, one should expect a
more pronounced toxicity compared with
control cells, due to FA cell deficiency in
withstanding oxidative stress. At the same
time, the failure to detect excess adduct for-
mation after Cr(VI) (Vilcheck et al. 2002) or
MMC (Rutherford et al. 1999) exposure does
not support a deﬁciency in removing damaged
DNA bases (i.e., in DNA repair).
In the same prospect, the use of FA cells
may be envisioned in forthcoming studies
designed to investigate the action mechanisms
of redox-related environmental agents or
pharmaceutical drugs.
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Table 3. Summary of the published evidence for the redox-dependent mechanisms in CDDP- and PUVA-
associated toxicity.
End points Observations References
CDDP
Nephrotoxicity Induction of heme oxygenase-1 Schaaf et al. (2002)
ROS formation Inhibited by antioxidants, α-tocopherol, Schaaf et al. (2002), 
vitamin C, and NAC De Martinis and Bianchi (2001)
GSH oxidation, ROS formation, Suppressed by NAC, enhanced by  Godbout et al. (2002)
and apoptosis methylglyoxal
Overexpression of oxidative ↑ Metallothionein (in vivo); Bauman et al. (1991),
stress-related genes ↑ p21waf1/Cip1 Waisﬁsz et al. (2002)
PUVA
ROS formation Reactions with DNA, lipids, and proteins; Reinheckel et al. (1999),
↓ Cellular antioxidant capacity; Punnonen et al. (1991)
↑ TBARS
Antioxidant enzyme expression ↓ Catalase and superoxide dismutase Punnonen et al. (1991)
GSH oxidation O2-dependent effect d’Ischia et al. (1989)
TBARS, thiobarbituric acid-reactive substances.
Table 4. Summary of the published evidence reporting on redox abnormalities in FA cellular phenotype.
Observed outcomes Tested/analyzed materials References
↓ Chromosomal instability by Cu/ZnSOD, Lymphocytes Nordenson (1977), Raj and
catalase, low-molecular-weight  Heddle (1980), Dallapiccola 
antioxidants, hypoxia (5% O2) et al. (1985), Joenje et al. 
(1981)
5% O2 corrects cell cycle arrest; Lymphoblastoid cell lines Poot et al. (1996)
free iron sensitivity
↑ 8-OHdG formation; sensitivity to H2O2; Lymphoblastoid cell lines Takeuchi and Morimoto (1993)
↓ catalase expression
↑ Levels of 8-OHdG; ↑ ROS formation; Freshly drawn WBCs from patients, Degan et al. (1995)
correlated with chromosomal instability siblings, and their parents
↑ Clastogenic factor Plasma from patients and parents Emerit et al. (1995)
↑ TNF-α and IFN-γ related to Plasma and WBCs from patients Schulz and Shahidi (1993),
iNOS in causing myelosuppression Pearl-Yafe et al. (2003), 
Dufour et al. (2003), Hadjur
and Jirik (2003)
Trx overexpression corrects MMC and Fibroblast cultures Ruppitsch et al. (1998)
DEB sensitivity; lower-than-normal  Kontou et al. (2002)
Trx levels
Abbreviations: IFN-γ, interferon-γ; iNOS, inducible nitric oxide synthase; Cu/ZnSOD, copper/zinc superoxide dismutase,
catalase; 8-OHdG, 8-hydroxy-2´-deoxyguanosine; TNF-α, tumor necrosis factor-α; WBCs, white blood cells.REFERENCES
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